EGFR T790M Mutation and Lung Cancer Risk in Non-Smokers

New research links a rare inherited EGFR T790M mutation to higher lung cancer risk in nonsmokers

“New research links a rare inherited EGFR T790M mutation to higher lung cancer risk in nonsmokers.” Lung cancer is often associated with smoking. But thousands of people who have never smoked are diagnosed with the disease every year. New research published in Science on September 17, 2026, has identified a rare inherited mutation that may … Read more

Fatigue in Adults: Latest CDC Data Shows How Common It Really Is

Fatigue Is Extremely Common in Adults: What the Latest CDC Data Show

Frequent fatigue should not automatically be dismissed as just being busy or getting older. Feeling tired after a busy day is normal. But when exhaustion keeps returning, even after rest, it may deserve closer attention. A new report from the U.S. Centers for Disease Control and Prevention (CDC) shows just how widespread fatigue has become … Read more

Alcohol and Cancer Risk: Why Even One Drink a Day Deserves a Second Thought

Alcohol and Cancer Risk: Why Even One Drink a Day May Increase Cancer Risk

Alcohol and Cancer Risk:Besides many studies,this article talks about the study as latest as 2nd September-2026-conveying the message:less alcohol generally means less alcohol-related cancer risk. For years, an occasional drink was often seen as harmless. New research suggests the picture is more complicated. A major US study published in The Lancet Regional Health – Americas … Read more

Semaglutide and Longevity: New Study Finds GLP-1 Drug May Slow Aging in Mice

Semaglutide and Longevity: New Study Finds GLP-1 Drug May Slow Aging in Mice

Semaglutide and longevity : Semaglutide may have longevity-related biological effects as proved by the latest experimental studies discussed here in details. GLP-1 medications have become widely known for their role in weight loss and blood sugar control. Now, new research is raising another intriguing question: could semaglutide also influence the biology of aging? A study … Read more

GLP-1 Weight-Loss Drugs for Men: Why More Men Are Turning to Them in 2026

Why More Men Are Turning to GLP-1 Weight-Loss Drugs in 2026

GLP-1 Weight-Loss Drugs for Men: Why More Men Are Turning to Them in 2026→ confident, informed male making a healthcare decision For years, weight loss was rarely discussed openly among men. A man was expected to lose weight through discipline, exercise and a better diet. If those methods failed, he was often told to try … Read more

Why Are Men Still Quiet About Using Weight-Loss Drugs?

Middle-aged man considering medical weight-loss treatment and GLP-1 medications

A middle-aged/older American man looking at himself in a mirror, thoughtful rather than unhappy, with a subtle weight-management-depicting the psyche of men and weight-loss drugs For years, men have been told that losing weight is mainly a test of discipline: eat less, exercise more and work harder. But what happens when diet and exercise are … Read more

GLP-1 Drugs and Male Fertility: What Researchers Know in 2026

GLP-1 drugs and male fertility: These medications could help male patients improve their testosterone levels and their fertility, a new study has found. GLP-1 medications have transformed the conversation around obesity and metabolic health. They are widely used to help eligible patients manage obesity and type 2 diabetes. Now researchers are asking whether the benefits … Read more

GLP-1 Drugs and Asthma: What New 2026 Research Shows

GLP-1 drugs and asthma-The latest 2026 research provides an encouraging signal for people living with both asthma and obesity. GLP-1 medications are best known for helping with obesity, type 2 diabetes and related metabolic conditions. But researchers are now examining whether these medicines may offer benefits beyond weight loss and blood-sugar control. One of the … Read more

GLP-1 Drugs for PMOS: What New Research Shows About Weight Loss and Hormone Balance

GLP-1 medicines are changing the way doctors approach obesity and metabolic health. Now, researchers are examining whether these medicines[GLP-1 drugs for PMOS] may also help women with polyendocrine metabolic ovarian syndrome (PMOS), the condition formerly known as polycystic ovary syndrome or PCOS. Early research is encouraging. A 2026 study of women with PMOS and obesity … Read more